| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/07/2002 | US6383802 Method and device for preparing samples for detecting a nucleotide sequence |
| 05/07/2002 | US6383795 Efficient purification of adenovirus |
| 05/07/2002 | US6383793 Human osteoclast-derived cathepsin |
| 05/07/2002 | US6383790 Pyrazolo(3,4-d)pyrimidine based compound; anticarcinogenic agents; antitumor agents |
| 05/07/2002 | US6383784 Construction of nucleoprotein based assemblies comprising addressable components for nanoscale assembly and nanoprocessors |
| 05/07/2002 | US6383783 Mixing nucleic acid sample with hydrophobic organic polymeric solid phase so that nucleic acid adheres to phase, then applying nonionic surfactant to remove adhered nucleic acid; can be automated; use of nontoxic reagents |
| 05/07/2002 | US6383780 2786, a novel human aminopeptidase |
| 05/07/2002 | US6383778 Nucleotide sequence which codes for receptor that binds to phenylthiocarbamide ligand; for taste modulating compounds for use in food and drug industries |
| 05/07/2002 | US6383771 Mixing sample of whole blood from subject which includes endogenous oxidoreductase with substrate for the enzyme, measuring amount of substrate reduced, and correlating that amount with energy producing capacity of cells in sample |
| 05/07/2002 | US6383768 Method for producing in vitro the RNA-dependent RNA polymerase and terminal nucleotidyl transferase activities encoded by hepatitis C virus (HCV) |
| 05/07/2002 | US6383765 Polypeptides of feline T-cell lymphotropic lentivirus |
| 05/07/2002 | US6383757 Methods of diagnosing community acquired pneumonia (CAP) and predisposition or susceptibility for CAP and associated septic shock through detection of gene polymorphisms |
| 05/07/2002 | US6383756 Method for non-radioactive detection of membrane-bonded nucleic acids and test kit |
| 05/07/2002 | US6383755 Amplifying template polydeoxyribonucleotide having at least one psuedo restriction endonuclease site with flanking primers, contacting with restriction endonuclease, detecting presence of cleavage products, relating products to accuracy |
| 05/07/2002 | US6383754 Incubating nucleic acid with cleaving reagents, mixing with offset adaptors that couple with nucleic acid fragments, incubating nucleic acids with cleaving reagents that create sticky ends, mixing and coupling adaptor-indexers to fragments |
| 05/07/2002 | US6383752 Oligonucleotide with a functional segment, a protecting segment complementary to part of the functional segment, and a linker which joins the segments together; the functional and protecting segments can hybridize together; stability |
| 05/07/2002 | US6383751 Assessing marbling score of cattle by testing animal for presence or absense of allele of 5' untranslated region of gene encoding thyroglobin; presence of allele 3 indicates high score, homozygositiy for allele 2 indicates low score |
| 05/07/2002 | US6383750 Generating free radicals at random positions along polymer, reacting with stable free radicals, attatching functional labelling groups to stable free radical derived groups before or after reaction with polymer chain |
| 05/07/2002 | US6383749 Solid supports |
| 05/07/2002 | US6383747 Method for determining ancestral haplotypes using haplospecific geometric elements within the major histocompatibility complex multigene cluster |
| 05/07/2002 | US6383746 Nucleotide sequence of regulatory sequence from chemokine receptor; for gene expression inhibition; antiinflammatory agents |
| 05/07/2002 | US6383745 Methods of screening for anti-microbial utilizing aarC and compositions thereof |
| 05/07/2002 | US6383743 Method for serial analysis of gene expression |
| 05/07/2002 | US6383742 Biochips having sheets made to form layers, each sheet having two dimensions of attatched oligonucleotide probes; diagnosis; forensics; genetic mapping |
| 05/07/2002 | US6383739 Drug screening by isolating blood cells then cd8+ cells from donors, culturing with compound for 3 days, culturing in with interleukin-2, detecting immunodeficiency-virus suppressing lymphokine expression, then further analysis |
| 05/07/2002 | US6383737 Consisting of a polynucleotide encoding the polypeptide comprising amino acid 1 to 578 of a specific amino acid sequence, a polynucleotide capable of hybridizing to above polynuceotide and a fragment of both polynucleotides |
| 05/07/2002 | US6383734 Method to determine inhibition of PAK3 activation of Raf-1 |
| 05/07/2002 | US6383393 Adsorption |
| 05/07/2002 | US6383138 Method for transdermal sampling of analytes |
| 05/07/2002 | CA2230059C Propargylethoxyamino nucleotides |
| 05/02/2002 | WO2002035240A2 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors |
| 05/02/2002 | WO2002035237A2 Method for in vivo identification of intracellular epitopes |
| 05/02/2002 | WO2002035235A2 Net as regulator of angiogenic expression |
| 05/02/2002 | WO2002035232A2 Method for detecting ovarian cancer based on human kallikrein 6 (hk6) |
| 05/02/2002 | WO2002035222A1 Biosensor |
| 05/02/2002 | WO2002035212A1 Method for the prediction of starch digestion |
| 05/02/2002 | WO2002034953A2 Detection and quantification of human herpes viruses |
| 05/02/2002 | WO2002034952A2 Screening assays |
| 05/02/2002 | WO2002034951A2 Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2) |
| 05/02/2002 | WO2002034950A2 Immobilization of biopolymers to aminated substrates by direct adsorption |
| 05/02/2002 | WO2002034949A2 Methods for identifying genes associated with diseases or specific phenotypes |
| 05/02/2002 | WO2002034948A2 Candidate region mismatch scanning for genotyping and mutation detection |
| 05/02/2002 | WO2002034947A2 Detecting specific nucleotide sequences |
| 05/02/2002 | WO2002034946A2 Cotton event pv-ghgt07(1445) and compositions and methods for detection thereof |
| 05/02/2002 | WO2002034945A2 Estrogen receptor alpha variants and methods of detection thereof |
| 05/02/2002 | WO2002034944A1 High precision and intellectual biochip arrayer having function of respotting |
| 05/02/2002 | WO2002034942A2 Nucleic acid amplification-based methods for the determination of a methylation profile and reagents therefor |
| 05/02/2002 | WO2002034941A1 Method for screening active molecules for treating and preventing atherosclerotic lesions and its uses |
| 05/02/2002 | WO2002034940A2 Methods for screening compounds that modulate lipid metabolism |
| 05/02/2002 | WO2002034939A2 Method of genomic analysis |
| 05/02/2002 | WO2002034938A1 Diagnostics and examination method for cancer of the colon using tannase as indication |
| 05/02/2002 | WO2002034937A2 Methods for detection of differences in nucleic acids |
| 05/02/2002 | WO2002034935A2 In vitro selection of signaling aptamers |
| 05/02/2002 | WO2002034933A2 Methods and compositions for modifying biologically active target molecules |
| 05/02/2002 | WO2002034922A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/02/2002 | WO2002034920A2 Regulation of human ceruloplasmin-like protein |
| 05/02/2002 | WO2002034919A1 Variants of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 05/02/2002 | WO2002034918A2 E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof |
| 05/02/2002 | WO2002034916A2 Novel mutant igbp-3 molecules that do not bind to igfs, but retain their ability to functionally bind igfbp-3 receptor |
| 05/02/2002 | WO2002034914A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 05/02/2002 | WO2002034913A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 05/02/2002 | WO2002034912A1 Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detecting them and therapeutic method and remedies for rheumatoid arthritis |
| 05/02/2002 | WO2002034911A1 Mfq-114, a human ajuba like protein |
| 05/02/2002 | WO2002034907A1 Method of synthesizing single-stranded nucleic acid |
| 05/02/2002 | WO2002034905A1 Method of gene amplification |
| 05/02/2002 | WO2002034903A2 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications |
| 05/02/2002 | WO2002034899A2 Tec kinase assay |
| 05/02/2002 | WO2002034891A2 Immortalized preosteoblasts and method for their production |
| 05/02/2002 | WO2002034883A2 A one-well assay for high throughput detection of single nucleotide polymorphisms |
| 05/02/2002 | WO2002034881A2 Compositions and methods for the discovery and selection of biological information |
| 05/02/2002 | WO2002034789A1 Monoclonal antibodies directed against hepatitis b viruses |
| 05/02/2002 | WO2002034783A2 Transmembrane proteins |
| 05/02/2002 | WO2002034289A1 Modulating angiogenesis |
| 05/02/2002 | WO2002034201A2 Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy |
| 05/02/2002 | WO2002034110A2 Method of determining global coagulability and hemostatic potential |
| 05/02/2002 | WO2002034109A2 A reagent and kit for determining global coagulability and hemostatic potential |
| 05/02/2002 | WO2002019812A3 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor |
| 05/02/2002 | WO2002008748A3 Ion channel assay methods |
| 05/02/2002 | WO2002008388A3 Stem cell-like cells |
| 05/02/2002 | WO2002008253A3 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY |
| 05/02/2002 | WO2002006460A3 Masp-2, a complement-fixing enzyme, and uses for it |
| 05/02/2002 | WO2002006294A3 Haplotypes of the mmp13 gene |
| 05/02/2002 | WO2002004523A3 Artificial antibody polypeptides |
| 05/02/2002 | WO2002003060A3 Process for the measurement of dinophysistoxin and of yessotoxin |
| 05/02/2002 | WO2001098330A3 A RECOMBINANT CELL LINE EXPRESSING GPCRx11 AS A FUNCTIONAL RECEPTOR VALIDATED BY ANGIOPEPTIN AND USEFUL FOR SCREENING OF AGONISTS AND ANTAGONISTS |
| 05/02/2002 | WO2001090745A3 Determination of naaladase inhibitors |
| 05/02/2002 | WO2001090147A3 Long wavelength engineered fluorescent proteins |
| 05/02/2002 | WO2001085994A3 Method and means for identifying hpv virus |
| 05/02/2002 | WO2001083555A3 Pain signaling molecules |
| 05/02/2002 | WO2001082774A3 Methods and compositions for the diagnosis of schizophrenia |
| 05/02/2002 | WO2001075166A3 Compositions and methods for detecting and quantifying gene expression |
| 05/02/2002 | WO2001074900A3 Nuclear factor kb inducing factor |
| 05/02/2002 | WO2001070771A3 Acute neuronal induced calcium binding protein type 1 ligand |
| 05/02/2002 | WO2001069245A3 Cross-reactive sensors |
| 05/02/2002 | WO2001069244A3 Method for labeling individual cells |
| 05/02/2002 | WO2001066772A3 Heparinase iii and uses thereof |
| 05/02/2002 | WO2001064741A3 Methods for selectively modulating survivin apoptosis pathways |
| 05/02/2002 | WO2001062923A3 Transporters and ion channels |
| 05/02/2002 | WO2001061009A3 Polypeptides and nucleic acids encoding same |
| 05/02/2002 | WO2001061008A3 Polypeptides and nucleic acids encoding same |